Can C. difficile toxins and dysbiosis disrupt the intestinal barrier and increase inflammation?

Infection with Clostridioides difficile and the concomitant overgrowth of opportunistic pathobionts severely compromise intestinal barrier integrity and drive localized immune activation.

Mechanisms of barrier disruption

• Toxin-mediated damage: C. difficile toxins A (TcdA) and B (TcdB) act as glucosyltransferases that glocoxylate and inactivate host Rho-family GTPases (including RhoA, Rac1, and Cdc42). This action collapses the perijunctional actin ring and causes key tight junction scaffolding and transmembrane proteins (ZO-1, occludin, and claudins) to redistribute and internalize, significantly decreasing transepithelial electrical resistance (TEER).
• Fluid loss: The physical breakdown of tight junctions drives leak-flux diarrhea, allowing water, solutes, and luminal antigens to pass freely into the intestinal lumen, directly worsening diarrheal and abdominal symptoms.

Dysbiosis and inflammatory cascades

• Pathobiont activation: Microbial dysbiosis permits the rapid expansion of Klebsiella and Streptococcus species. Klebsiella lipopolysaccharide (LPS) activates Toll-like receptor 4 (TLR4), while Streptococcus cell wall components (peidoglycan and lipoteichoic acid) engage TLR2.
• Cytokine signaling: These TLR interactions initiate MyD88-dependent pathways that drive the nuclear translocation of NF-κB, triggering the transcription and secretion of pro-inflammatory cytokines including IL-1β, IL-6, IL-18, and TNF-α.
• Immune recruitment: Concurrently, TcdA and TcdB prompt epithelial cells to release IL-8, driving massive mucosal neutrophil infiltration and subsequent tissue necrosis. Klebsiella overgrowth further amplifies this inflammatory loop via caspase-11-dependent epithelial inflammasome activation and Th1/Th17 polarization.

Bottom line

• C. difficile toxins directly dismantle the intestinal tight junction barrier to cause leak-flux diarrhea, while concurrent dysbiotic overgrowth of Klebsiella and Streptococcus synergistically amplifies mucosal inflammation through TLR-mediated NF-κB and inflammasome activation.